Skip to content

Injecting drug users more likely to die when taking HAART, but HIV not the reason

High incidence of IRIS amongst HIV-positive TB patients starting HAART in India

HAART and adverse events during pregnancy explored in European study

Can HIV infection occur through the lining of the mouth?

Tipranavir expanded access programme begins in US

Women and girls must have equal access to HIV treatment, say WHO and UNAIDS

Two Cipla antiretrovirals return to WHO prequalification list

Dendritic-cell treatment boosts therapeutic vaccine prospects

Four days of nevirapine plus a month of 2 NRTIs appears to be ‘safe’ PEP strategy